Skip to main content
. 2026 Feb 27;18(5):764. doi: 10.3390/cancers18050764
AUC Area under the concentration–time curve
GOG Gynecologic Oncology Group
IDS Interval debulking surgery
IP Intraperitoneal
IV Intravenous
NAC Neoadjuvant chemotherapy
OS Overall survival
PARP Poly(ADP-ribose) polymerase
PDS Primary debulking surgery
PFS Progression-free survival
QOL Quality of life